The expanding field of short-chain protein therapeutics represents a notable paradigm shift in how we approach disease and maximize athletic performance. Unlike traditional small molecules, peptidic compounds offer remarkable specificity, often interacting with specific receptors or enzymes with unprecedented accuracy. This focused action minimizes